Jinluan Chen

Jinluan Chen is a Researcher at Erasmus MC's Department of Internal Medicine, focusing on advanced glycation end products (AGEs) and their associations with metabolic, cardiovascular, and neurological disorders. Their work spans biomarker discovery, epidemiological studies, and microbiota interactions. Key contributions include investigations into AGE-RAGE pathways in chronic diseases, skin autofluorescence as a biomarker, and the Rotterdam Study's insights into CVD and dementia risks.

Research interests integrate metabolic disorders, pulmonary diseases, and microbiota dynamics. Recent studies highlight the role of AGEs in pediatric syndromes and dietary influences on microbiota. Collaborations emphasize population-based cohort analyses and translational research.

Publications span 2023–2025, with a focus on open-access contributions to journals like Scientific Reports and Cardiovascular Diabetology. No explicit awards are noted, but impactful research is evident through citations and media mentions.